Gingicaine Gel, Cherry
Product Images NDC 10129-715

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Gingicaine Gel, Cherry (NDC 10129-715). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gingi-pak A Division Of The Belport, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Keep Out Of Reach Of Children (Children Page 001)

This text provides a warning message advising that Gingicaine Gel products should be kept away from children, and if ingested or swallowed, a doctor should be contacted immediately while following the given instructions.*

FDA Label Image

Contraindications

This text appears to be a warning about the use of a particular product (likely a local anesthetic) and its potential contraindications. It advises not to use the product on patients who have a history of hypersensitivity to ester-type local anesthetics. It also warns against using the product for teething and in infants and children under the age of 2 years.*

FDA Label Image

Gingicaine Cherry Jar Label

FDA Label Image

Active Ingredients (Gingicaine Active Ingredients 001)

This is a description of an oral anesthetic containing benzocaine as the active ingredient in 20% concentration.*

FDA Label Image

Allergy Alert (Gingicaine Allergy Alert 001)

The text is a warning about the allergy caused due to the usage of certain local anesthetics, and mentions a specific allergen to avoid.*

FDA Label Image

Avoid Excessive Heat (Gingicaine Avoid Excessive Heat)

This text is a warning to avoid exposing something to temperatures above 40 degrees Celsius or 104 degrees Fahrenheit to prevent damage or danger.*

FDA Label Image

Consult A Doctor Promptly (Gingicaine Consult A Doctor Gingicaine)

FDA Label Image

Dosage And Administration001 (Gingicaine Dosage And Admin 001)

FDA Label Image

Dosage And Administration002 (Gingicaine Dosage And Admin 002)

This text provides instructions and precautions for the use of a local anesthetic. It advises using cotton rolls or saliva ejectors to prevent dilution of the anesthetic and sterile cotton or gauze to avoid cross-contamination. The recommended dose should not be exceeded and the product should be applied to the affected area and left in place for at least one minute. It can be used up to four times daily by adults and children over two years old. Children under two years old should seek advice from a doctor or dentist.*

FDA Label Image

​indications (Gingicaine Indications 001)

This text provides information about the indications of a product that can be used to anesthetize the mucous membranes in the oropharynx area. It helps in reducing the pain caused by ulcers, needle puncture, deep scaling procedures, and the application of matrix bands. In addition, it can also be used as an aid during the process of taking impressions or intraoral radiographs especially for patients who have an excessive gag reflex.*

FDA Label Image

Precautions (Gingicaine Precaution 001)

This text provides precautions for dentists when using local anesthetics. It suggests avoiding application in certain areas and being cautious when working with patients who have known drug sensitivities or allergies to certain types of anesthetics. The text emphasizes the need for dentists to be mindful of the risk of sensitization and to take steps to avoid contact with these substances.*

FDA Label Image

Uses (Gingicaine Uses 001)

This text describes the usage of a product that can reduce pain and discomfort caused by minor dental procedures, minor gum injuries, canker sores, sore throat, and minor mouth or gum irritations caused by dentures or orthodontic appliances.*

FDA Label Image

Inactive Ingredients (Inactive Ingredient Page 001)

Polyethylene Glycol 3350 and Polyethylene Glycol 400 are types of polyethylene glycols which are often used as laxatives to treat constipation. Potassium Sodium Saccharate is a type of artificial sweetener used in food and beverages.*

FDA Label Image

Purpose (Purpose Page 001)

Gingicaine Gel is a numbing medication that is applied onto the gums by dentists before administering an injection. This helps to reduce pain and discomfort experienced by the patient.*

FDA Label Image

Warnings

This text provides warnings and precautions for the use of a certain product, indicating that it is for external use only. It also warns that the use of the product can cause a rare condition called methemoglobinemia, which may reduce oxygen in the blood. The user should stop using the product immediately and seek medical attention if they develop symptoms such as pale or blue skin, headache, rapid heartbeat, shortness of breath, dizziness, lightheadedness, fatigue or lack of energy. Additionally, the product should not be used for children under 2 years of age.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.